Literature DB >> 18452976

Location of the multimerin 1 binding site in coagulation factor V: an update.

Samira B Jeimy1, Mary Ann Quinn-Allen, Nola Fuller, William H Kane, Catherine P M Hayward.   

Abstract

Activated coagulation factor V (FVa) is an important cofactor that accelerates thrombin production. In human blood, 25% of the factor V (FV) is stored in platelets, complexed to the polymeric, FV binding protein multimerin 1 (MMRN1). The light chain of FV is required for MMRN1 binding, and its C2 domain contains a MMRN1 binding site that overlaps phospholipid binding residues essential for FVa procoagulant function. The homologous structures and roles of the FVa light chain C1 and C2 domains led us to investigate if the C1 domain also contains a MMRN1 binding site. The MMRN1 binding properties of FV constructs were tested by modified enzyme-linked immunoassays, before and after thrombin activation. The constructs tested included the combined C1 and C2 domain deleted FV, and B-domain deleted forms of FV containing C1 domain point mutations or combined C1 and C2 domain phospholipid binding site mutations. The MMRN1 binding site in FV/FVa was mapped to a large region that included the C1 domain phospholipid binding residues Y1956 and L1957. The FV construct with combined C1 and C2 domain phospholipid binding site mutations had no MMRN1 binding, highlighting the critical role of the FV C1 and C2 domain phospholipid binding residues in MMRN1 binding. Our data update the information on the structural features of FV and FVa important for MMRN1 binding, and suggest that the extended MMRN1 binding site in the C1 and C2 domains is important for the storage of FV-MMRN1 complexes in platelets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452976      PMCID: PMC2648837          DOI: 10.1016/j.thromres.2008.03.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  14 in total

1.  Crystal structures of the membrane-binding C2 domain of human coagulation factor V.

Authors:  S Macedo-Ribeiro; W Bode; R Huber; M A Quinn-Allen; S W Kim; T L Ortel; G P Bourenkov; H D Bartunik; M T Stubbs; W H Kane; P Fuentes-Prior
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

2.  The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.

Authors:  Mahasen Saleh; Weimin Peng; Mary Ann Quinn-Allen; Sandra Macedo-Ribeiro; Pablo Fuentes-Prior; Wolfram Bode; William H Kane
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

3.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

4.  Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activation.

Authors:  W Peng; M A Quinn-Allen; W H Kane
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

5.  Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding.

Authors:  T Izumi; S W Kim; A Greist; S Macedo-Ribeiro; P Fuentes-Prior; W Bode; W H Kane; T L Ortel
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

6.  Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.

Authors:  S W Kim; M A Quinn-Allen; J T Camp; S Macedo-Ribeiro; P Fuentes-Prior; W Bode; W H Kane
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

7.  Human platelets contain forms of factor V in disulfide-linkage with multimerin.

Authors:  Catherine P M Hayward; Nola Fuller; Shilun Zheng; Frédéric Adam; Samira B Jeimy; Ian Horsewood; Mary Ann Quinn-Allen; William H Kane
Journal:  Thromb Haemost       Date:  2004-12       Impact factor: 5.249

8.  A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.

Authors:  M Jacquemin; A Benhida; K Peerlinck; B Desqueper; L Vander Elst; R Lavend'homme; R d'Oiron; R Schwaab; M Bakkus; K Thielemans; J G Gilles; J Vermylen; J M Saint-Remy
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  Identification of the MMRN1 binding region within the C2 domain of human factor V.

Authors:  Samira B Jeimy; Rachael A Woram; Nola Fuller; Mary Ann Quinn-Allen; Gerry A F Nicolaes; Bjorn Dahlbäck; William H Kane; Catherine P M Hayward
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

10.  Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.

Authors:  T L Ortel; D Devore-Carter; M Quinn-Allen; W H Kane
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  1 in total

Review 1.  Multimerin-1 and cancer: a review.

Authors:  Mareike G Posner
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.